Madhava C Reddy

Dr. Madhava C Reddy

Biotechnology and Bioinformatics, Yogi Vemana University, Kadapa, India

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2000 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MRMadhava C Reddy
Madhava C Reddy
VBVadiraja B. Bhat
Vadiraja B. Bhat
GKG. Kiranmai
G. Kiranmai
MRM.Narsa Reddy
M.Narsa Reddy
PRP. Reddanna
P. Reddanna
KMK.M. Madyastha
K.M. Madyastha

1 August 2004 in Biochemical Pharmacology
Verified
Journal Article
Closed access
JSJagu Subhashini
Jagu Subhashini
SMSuraneni V.K Mahipal
Suraneni V.K Mahipal
MRMadhava C Reddy
Madhava C Reddy
MRMetukuri Mallikarjuna Reddy
Metukuri Mallikarjuna Reddy
ARAparna Rachamallu
Aparna Rachamallu
PRPallu Reddanna
Pallu Reddanna

1 May 2003 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MRMadhava C Reddy
Madhava C Reddy
JSJ Subhashini
J Subhashini
SMS.V.K Mahipal
S.V.K Mahipal
VBVadiraja B Bhat
Vadiraja B Bhat
PRP Srinivas Reddy
P Srinivas Reddy
PRP Reddanna
P Reddanna

18 July 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
R. R. PallavaliR. R. Pallavali
R. R. Pallavali
VDVijaya Lakshmi Degati
Vijaya Lakshmi Degati
DLDakshayani Lomada
Dakshayani Lomada
MRMadhava C Reddy
Madhava C Reddy
DPDurbaka Vijaya Raghava Prasad
Durbaka Vijaya Raghava Prasad
Multi-drug resistance has become a major problem for the treatment of pathogenic bacterial infections. The use of bacteriophages is an attractive approach to overcome the problem of drug resistance in several pathogens that cause fatal diseases. Our study aimed to isolate multi drug resistant bacteria from patients with septic wounds and then isolate and apply bacteriophages in vitro as alternative therapeutic agents. Pus samples were aseptically collected from Rajiv Gandhi Institute of Medical Science (RIMS), Kadapa, A.P., and samples were analyzed by gram staining, evaluating morphological characteristics, and biochemical methods. MDR-bacterial strains were collected using the Kirby-Bauer disk diffusion method against a variety of antibiotics. Bacteriophages were collected and tested in vitro for lytic activity against MDR-bacterial isolates. Analysis of the pus swab samples revealed that the most of the isolates detected had Pseudomonas aeruginosa as the predominant bacterium, followed by Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli. Our results suggested that gram-negative bacteria were more predominant than gram-positive bacteria in septic wounds; most of these isolates were resistant to ampicillin, amoxicillin, penicillin, vancomycin and tetracycline. All the gram-positive isolates (100%) were multi-drug resistant, whereas 86% of the gram-negative isolates had a drug resistant nature. Further bacteriophages isolated from sewage demonstrated perfect lytic activity against the multi-drug resistant bacteria causing septic wounds. In vitro analysis of the isolated bacteriophages demonstrated perfect lysis against the corresponding MDR-bacteria, and these isolated phages may be promising as a first choice for prophylaxis against wound sepsis, Moreover, phage therapy does not enhance multi-drug resistance in bacteria and could work simultaneously on a wide variety of MDR-bacteria when used in a bacteriophage cocktail. Hence, our results suggest that these bacteriophages could be potential therapeutic options for treating septic wounds caused by P. aeruginosa, S. aureus, K. pneumoniae and E. coli.

17 May 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Lebaka Veeranjaneya ReddyLebaka Veeranjaneya Reddy
Lebaka Veeranjaneya Reddy
PRPERUGU Ravi
PERUGU Ravi
MRMadhava C Reddy
Madhava C Reddy
TCThummala Chandrasekhar
Thummala Chandrasekhar
Tapas MandalTapas Mandal
Tapas Mandal
Zinc oxide nanoparticles (ZnO NPs) have garnered significant attention across various scientific and technological domains due to their unique physicochemical properties, including high surface area, photostability, biocompatibility, and potent antimicrobial activity. These attributes make ZnO NPs highly versatile, enabling their application in biomedicine, environmental science, industry, and agriculture. They serve as effective antimicrobial agents in medical treatments and as catalysts in environmental purification processes, owing to their ability to generate reactive oxygen species (ROS) and exhibit photocatalytic activity under UV light. Moreover, ZnO NPs are being increasingly employed in advanced drug delivery systems and cancer therapies, highlighting their potential in modern medicine. Their growing popularity is further supported by their ease of synthesis, cost-effectiveness, and capacity for diverse functionalization, which expand their utility across multiple sectors. This review focuses on research from the past five years (2020–2025) on the practical uses of ZnO nanoparticles in the biomedical, environmental, industrial, and agricultural fields. It also highlights current trends, existing challenges, and future perspectives. By examining these aspects, the article provides a comprehensive understanding of the versatile roles of ZnO NPs and their emerging significance in science and technology.

1 October 2006 in Reproductive Toxicology
Verified
Journal Article
Closed access
MRMallikarjuna M. Reddy
Mallikarjuna M. Reddy
SMSuraneni V.K. Mahipal
Suraneni V.K. Mahipal
JSJagu Subhashini
Jagu Subhashini
MRMadhava C Reddy
Madhava C Reddy
KRKarnati R. Roy
Karnati R. Roy
PRPallu Reddanna
Pallu Reddanna